|
Multiple Vaccines & the Immune System
|
|
|
Multiple Vaccines & the Immune Syste... Clinical Trials
- Phase I/II Study of Safety & Efficacy of Perifosine & Bortezomib With or Without Dexamethasone for Multiple Myeloma Patients
ClinicalTrials.gov Identifier: NCT00401011 - Recruiting
Multiple Myeloma; Relapsed or Refractory Multiple Myeloma
- Booster Vaccination Study to Assess Immune Response & Safety of a Dose of GSK Biologicals’ Mencevax™ ACWY at 24-30 Mths Age & to Assess Immune Response & Safety of 1/5th of a Dose of Mencevax™ ACWY at 30-36 Mths Age in Subjects Primed in
ClinicalTrials.gov Identifier: NCT00291343 - Active, not recruiting
Diphtheria; Tetanus; Pertussis; Hepatitis B; Hib Diseases; Neisseria Meningitidis Serogroups A & C Diseases
- Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Diphtheria, Tetanus & Pertussis Vaccine (DTaP) Vaccine & a Haemophilus Influenza Type B (Hib) Vaccine in Healthy Children 15 m of Age
ClinicalTrials.gov Identifier: NCT00197236 - Active, not recruiting
Hepatitis A
- Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00004744 - Active, not recruiting
Multiple Sclerosis
- Evaluate the Effect of Several Risk Factors That Are Likely to Influence the Immunogenicity of Combined Hepatitis A & B Vaccine vs Monovalent Hepatitis A & Hepatitis B Vaccines
ClinicalTrials.gov Identifier: NCT00289731 - Active, not recruiting
Hepatitis A; Hepatitis B
- T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant
ClinicalTrials.gov Identifier: NCT00048464 - Active, not recruiting
Multiple Myeloma
- Trauma Registration at St. Olavs Hospital 2000-2003
ClinicalTrials.gov Identifier: NCT00184470 - Active, not recruiting
Injuries, Multiple; Norway/Epidemiology; Trauma Centers/Statistics & Numerical Data; Trauma, Multiple; Trauma Severity Indices
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination
ClinicalTrials.gov Identifier: NCT00291954 - Active, not recruiting
Hepatitis B Infection
- Safety and Immune Response of Different Pediatric Combination Vaccines.
ClinicalTrials.gov Identifier: NCT00255047 - Active, not recruiting
Diphtheria; Polio; Pertussis
- Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Measles/Mumps/Rubella Vaccine & a Varicella (Chickenpox) Vaccine in Healthy Children
ClinicalTrials.gov Identifier: NCT00197015 - Recruiting
Hepatitis A
- Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00124579 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines
ClinicalTrials.gov Identifier: NCT00443131 - Active, not recruiting
Plasmodium Falciparum Malaria
- Evaluation of the Safety and Effectiveness of a Probiotic Bacterium to Boost the Immune Response to Influenza Vaccines
ClinicalTrials.gov Identifier: NCT00294788 - Active, not recruiting
Influenza
- Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children
ClinicalTrials.gov Identifier: NCT00383123 - Active, not recruiting
Influenza
- Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00114101 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents
ClinicalTrials.gov Identifier: NCT00297817 - Active, not recruiting
Prevention of Meningococcal Disease
- Using Telephone Technology to Prevent Relapse After Alcoholism Treatment
ClinicalTrials.gov Identifier: NCT00132795 - Recruiting
Alcoholism
- Beta Alethine in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00006466 - Active, not recruiting
monoclonal gammopathy of undetermined significance; stage I multiple myeloma; stage II multiple myeloma; extramedullary plasmacytoma; ...
- Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children
ClinicalTrials.gov Identifier: NCT00192491 - Active, not recruiting
Influenza
- Escalating Multiple-Dose Phase 1 Safety, Tolerability & PK Trial 21 Days in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00431951 - Active, not recruiting
Healthy
- Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults
ClinicalTrials.gov Identifier: NCT00270218 - Active, not recruiting
HIV Infections
- Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00002787 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge
ClinicalTrials.gov Identifier: NCT00411697 - Active, not recruiting
Hepatitis B
- L-Dihydroxyphenylserine (L-DOPS) for Norepinephrine Deficiency: Interactions With Carbidopa and Entacapone
ClinicalTrials.gov Identifier: NCT00547911 - Recruiting
Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System Diseases
- Smoking Cessation for Young Adults Who Binge Drink - 1
ClinicalTrials.gov Identifier: NCT00218452 - Recruiting
Adherence; Tobacco use cessation; alcohol & drug use; nicotine transdermal system
- Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Mth Schedule in Healthy Children
ClinicalTrials.gov Identifier: NCT00289744 - Active, not recruiting
Hepatitis A; Hepatitis B
- Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults
ClinicalTrials.gov Identifier: NCT00289770 - Active, not recruiting
Hepatitis A; Hepatitis B
- Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children with Weakened Immune Systems
ClinicalTrials.gov Identifier: NCT00006066 - Active, not recruiting
HIV Infections
- Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adult Subjects
ClinicalTrials.gov Identifier: NCT00289718 - Active, not recruiting
Hepatitis A; Hepatitis B
- Influence of Corn Farming on the Immune System
ClinicalTrials.gov Identifier: NCT00342121 - Active, not recruiting
Cancer Risk
- AMP as a Better Delivery System of Adenosine
ClinicalTrials.gov Identifier: NCT00179010 - Recruiting
Ischemia
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00112879 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Examine the Safety & Immune Response of GSK Biologicals' Experimental Malaria Vaccine RTS,S/AS02D, When Administered to Infants Living in Malaria-Endemic Region
ClinicalTrials.gov Identifier: NCT00197028 - Active, not recruiting
Plasmodium Falciparum Malaria
- COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & AOM Efficacy Study of the Pneumococcal Conjugate Vaccine
ClinicalTrials.gov Identifier: NCT00466947 - Recruiting
Pneumonia & AOM Caused by S. Pneumoniae & H. Influenzae
- Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor
ClinicalTrials.gov Identifier: NCT00095329 - Completed
Multiple Sclerosis
- Clinical & Web-Based Diet & Activity Counseling for Men
ClinicalTrials.gov Identifier: NCT00412633 - Active, not recruiting
Obesity
- A Study to Evaluate Rituximab in Adults with Relapsing Remitting Multiple Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00097188 - Active, not recruiting
Multiple Sclerosis
- Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00088855 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
Hypertension; Diabetes
- 24-Hour IOP & Blood Pressure Control in POAG & OHT Patients
ClinicalTrials.gov Identifier: NCT00330577 - Active, not recruiting
Primary Open Angle Glaucoma; Ocular Hypertension
- Combination Chemotherapy and Interferon alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma
ClinicalTrials.gov Identifier: NCT00002599 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Primary & Booster Study in Infants to Demonstrate Non-Inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine.
ClinicalTrials.gov Identifier: NCT00327184 - Active, not recruiting
H.Influenzae Type b Disease; Meningococcal Serogroup C Diseases
- Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00004903 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
ClinicalTrials.gov Identifier: NCT00440973 - Active, not recruiting
Carcinoma, Renal Cell
- Bortezomib in Combination with CC-5013 in Patients with Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00153933 - Active, not recruiting
Refractory Multiple Myeloma; Relapsed Multiple Myeloma; Multiple Myeloma
- Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors
ClinicalTrials.gov Identifier: NCT00201812 - Active, not recruiting
Tumors
- A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults
ClinicalTrials.gov Identifier: NCT00437229 - Active, not recruiting
Healthy Adult Volunteer
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002556 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003490 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis Patients
ClinicalTrials.gov Identifier: NCT00416013 - Active, not recruiting
Kidney Failure, Chronic; Heart Failure, Congestive
- Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants
ClinicalTrials.gov Identifier: NCT00325156 - Active, not recruiting
Infant; Healthy
- Combination Chemotherapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00002678 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- The Immune System and Psychiatric Disorders
ClinicalTrials.gov Identifier: NCT00184418 - Active, not recruiting
Stress; Depression; Mania; Personality Disorders; Schizophrenia
- Safety, PD & PK of Multiple Doses of HematideTM Injections for Anemia in Chronic Kidney Disease Patients
ClinicalTrials.gov Identifier: NCT00228436 - Active, not recruiting
Anemia; Chronic Kidney Disease
- Dexamethasone With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00064038 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- BEYOND Study - Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
ClinicalTrials.gov Identifier: NCT00099502 - Active, not recruiting
Multiple Sclerosis
- Safety & Immunogenicity: Primary Study: Zoster-003, Extension Studies: Zoster-011,012&013 (EXT Zoster-003 Y1,Y2 &Y3)
ClinicalTrials.gov Identifier: NCT00434577 - Recruiting
Herpes Zoster; Shingles
- Long Term Follow-up Studies at Yrs 2,3,4 & 5, Where 2 Formulations of the Combined Hepatitis A & B Vaccine Was Compared
ClinicalTrials.gov Identifier: NCT00197184 - Active, not recruiting
Hepatitis A; Hepatitis B
- Melphalan, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003954 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
ClinicalTrials.gov Identifier: NCT00582647 - Recruiting
Esophageal Cancer; Bile Duct Neoplasms; Gastric Cancer; Liver Cancer; Melanoma; Pancreatic Cancer; Sarcoma
- Safety of RG2077 in Patients With Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00076934 - Active, not recruiting
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting
- Combination Chemotherapy With or Without Thalidomide in Treating Patients With Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005834 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Phase III Randomized Study of Melphalan With or Without Holmium Ho 166 DOTMP Followed By Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00008229 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs
ClinicalTrials.gov Identifier: NCT00257127 - Active, not recruiting
HIV Infections
- Rebif® New Formulation in Relapsing Forms of Multiple Sclerosis (RMS)
ClinicalTrials.gov Identifier: NCT00110396 - Active, not recruiting
Multiple Sclerosis
- Human Immune Globulin in Treating Patients With Primary Amyloidosis That is Causing Heart Dysfunction
ClinicalTrials.gov Identifier: NCT00547365 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Combination Therapy with Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00037102 - Active, not recruiting
Multiple Sclerosis
- Study to Evaluate Safety & Effectiveness of Vascular Sealant System
ClinicalTrials.gov Identifier: NCT00439309 - Recruiting
Peripheral Vascular Disease
- Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
ClinicalTrials.gov Identifier: NCT00296309 - Active, not recruiting
Kidney Transplantation
- Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00017602 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00003603 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
ClinicalTrials.gov Identifier: NCT00458120 - Recruiting
Dengue Hemorrhagic Fever
- Tandem Autologous Stem Cell Transplantation With or Without Maintenance Therapy After the Second Transplantation Compared With Autologous Stem Cell Transplantation Followed By Matched Sibling Allogeneic Stem Cell Transplantation in Patients With Stage II
ClinicalTrials.gov Identifier: NCT00075829 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- How Smoking Causes COPD: Examination of Immune System Changes
ClinicalTrials.gov Identifier: NCT00186719 - Recruiting
Chronic Obstructive Pulmonary Disease
- Effects of Massage on the Immune System of Preterm Infants
ClinicalTrials.gov Identifier: NCT00317278 - Recruiting
Premature Birth; Stress
- Effects of Pregabalin, Duloxetine & Amitriptyline on Pain & Sleep
ClinicalTrials.gov Identifier: NCT00370656 - Recruiting
Diabetes Mellitus; Peripheral Neuropathies
- A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation
ClinicalTrials.gov Identifier: NCT00275262 - Recruiting
Hodgkin''s Disease, Non-Hodgkin''s Lymphoma, Multiple Myeloma
- Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD
ClinicalTrials.gov Identifier: NCT00499863 - Recruiting
ADHD
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00005792 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients with Relapsed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00080405 - Active, not recruiting
Multiple Myeloma
- Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00040937 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- Investigation of the Human Immune Response in Normal Subjects and Patients with Disorders of the Immune System and Cancer
ClinicalTrials.gov Identifier: NCT00001582 - Recruiting
Communicable Disease; Immunologic Deficiency Syndrome; Neoplasm
- Organ Preservation: Weekly Carboplatin & Taxol w/Concurrent RT for Locally Advanced Laryngeal & Hypopharyngeal CA
ClinicalTrials.gov Identifier: NCT00534729 - Active, not recruiting
Laryngeal Neoplasms; Hypopharyngeal Neoplasms
- Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD
ClinicalTrials.gov Identifier: NCT00499590 - Recruiting
Macular Degeneration
- Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter in Achival & Frozen Tissue Sample
ClinicalTrials.gov Identifier: NCT00568438 - Recruiting
Breast Cancer
- Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006219 - Active, not recruiting
Multiple Myeloma
- Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00006890 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00014508 - Active, not recruiting
refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
- HIV-1 Vaccine Test in Uninfected Adult Volunteers
ClinicalTrials.gov Identifier: NCT00047931 - Active, not recruiting
HIV Seronegativity; AIDS Vaccines
- Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients with Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00095680 - Active, not recruiting
Multiple Myeloma
- A Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis
ClinicalTrials.gov Identifier: NCT00087529 - Active, not recruiting
Multiple Sclerosis
- Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK of B-Domain Deleted Recombinant FVIII
ClinicalTrials.gov Identifier: NCT00543439 - Recruiting
Hemophilia A
- High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
ClinicalTrials.gov Identifier: NCT00002630 - Active, not recruiting
stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
- Safety and efficacy of single-agent CC-5013 in subjects with relapsed and refractory multiple myeloma
ClinicalTrials.gov Identifier: NCT00065351 - Active, not recruiting
Multiple Myeloma
- Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI
ClinicalTrials.gov Identifier: NCT00172575 - Recruiting
Lung Neoplasms
- Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00002850 - Recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection
- Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents
ClinicalTrials.gov Identifier: NCT00091702 - Active, not recruiting
HIV Infections; Influenza
- VELCADE/Melphalan/Prednisone Versus Melphalan/Prednisone in Patients with Previously Untreated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00111319 - Active, not recruiting
Multiple Myeloma
- Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00024466 - Active, not recruiting
stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
